A private hospital in Johor Bahru has seen its number of patients from Singapore double since the COVID-19 pandemic [1].
The surge highlights a growing trend of Singaporeans seeking lower-cost medical alternatives across the border. By utilizing specific government-backed funding, patients can access specialized care in Malaysia while managing the financial burden of healthcare.
The facility is the only private hospital in Johor Bahru that participates in Singapore's overseas MediSave scheme [1]. This program allows Singaporean citizens to use their MediSave funds for approved treatments abroad, making the city an attractive destination for those looking to reduce out-of-pocket expenses.
Data from the hospital shows that 90% of these Singaporean patients are women [2]. The vast majority of these individuals are seeking maternity care [1]. The ability to use MediSave funds for childbirth, and related services, in Malaysia has made the facility a primary choice for expectant mothers.
While the Johor Bahru hospital has seen significant growth, it is not the only option for Singaporeans using this scheme. Only one other overseas MediSave participating hospital exists, located in Malacca [1].
The increase in cross-border medical travel has persisted since 2020, as the region recovered from pandemic-era travel restrictions [1]. The convenience of the Johor Bahru location, combined with the financial flexibility of the MediSave scheme, continues to drive the volume of patients crossing the border for medical needs.
“Patient numbers from Singapore have doubled since the pandemic.”
The shift toward maternity care in Johor Bahru suggests that Singaporeans are increasingly leveraging bilateral healthcare accessibility to offset the high costs of domestic private obstetric services. This trend underscores the importance of the overseas MediSave scheme in providing a financial safety valve for citizens, while simultaneously strengthening the medical tourism economy in Southern Malaysia.
